Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.diabres.2011.08.028PMID 21945031
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.

  2011cited by this paper
• Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy

  2011cited by this paper
• Adiponectin and leptin in chronic kidney disease: causal factors or mere risk markers?

  2011cited by this paper
• Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy.

  2011cited by this paper
• T-cell cytokine production and endothelial dysfunction in type 2 diabetic patients with nephropathy.

  2009cited by this paper
• Adipocytokines are associated with renal function in patients with normal range glomerular filtration rate and type 2 diabetes.

  2009cited by this paper
• Correlation between Circulating Adhesion Molecule Levels and Albuminuria in Type-2 Diabetic Hypertensive Patients

  2009cited by this paper
• Determinants of plasma adiponectin levels in nondiabetic subjects with moderate to severe chronic kidney disease.

  2009cited by this paper
• Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study

  2008cited by this paper
• MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.

  2008influential reference
• Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial

  2008cited by this paper
• Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years

  2008cited by this paper
• Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention.

  2008cited by this paper
• Adiponectin regulates albuminuria and podocyte function in mice.

  2008cited by this paper
• Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria.

  2008cited by this paper
• Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy

  2008cited by this paper
• Adiponectin and renal disease progression: another epidemiologic conundrum?

  2007cited by this paper
• Exacerbation of Albuminuria and Renal Fibrosis in Subtotal Renal Ablation Model of Adiponectin-Knockout Mice

  2007cited by this paper
• Adiponectin--an adipokine with unique metabolic properties.

  2007cited by this paper
• Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo.

  2007cited by this paper
• Getting to the site of inflammation: the leukocyte adhesion cascade updated

  2007cited by this paper
• Correlation between circulating adhesion molecule levels and albuminuria in type 2 diabetic normotensive patients.

  2007cited by this paper
• Increased Serum High-Molecular-Weight Complex of Adiponectin in Type 2 Diabetic Patients with Impaired Renal Function

  2006cited by this paper
• Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy

  2006cited by this paper
• Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease.

  2006cited by this paper
• Macrophage accumulation in human progressive diabetic nephropathy

  2006cited by this paper
• Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy.

  2006cited by this paper
• Adiponectin level is reduced and inversely correlated with the degree of proteinuria in type 2 diabetic patients.

  2005cited by this paper
• Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.

  2005cited by this paper
• Adiponectin Inhibits Endothelial Synthesis of Interleukin-8

  2005cited by this paper
• Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.

  2004cited by this paper
• Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis.

  2004cited by this paper
• Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes.

  2004cited by this paper
• Multiple Abnormalities in Glucose and Energy Metabolism and Coordinated Changes in Levels of Adiponectin, Cytokines, and Adhesion Molecules in Subjects With Metabolic Syndrome

  2004cited by this paper
• Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.

  2003cited by this paper
• Plasma adiponectin and endogenous glucose production in humans.

  2003cited by this paper
• Adiponectin: more than just another fat cell hormone?

  2003cited by this paper
• Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes.

  2003influential reference
• Plasma Soluble Intercellular Adhesion Molecule 1 Levels Are Increased in Type 2 Diabetic Patients with Nephropathy

  2002cited by this paper
• A simplified equation to predict glomerular filtration rate from serum creatinine

  2000cited by this paper
• Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

  2000cited by this paper
• Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.

  2000cited by this paper
• Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

  2000cited by this paper
• Activation of the amiloride-sensitive epithelial sodium channel by the serine protease mCAP1 expressed in a mouse cortical collecting duct cell line.

  2000cited by this paper
• Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty.

  1996cited by this paper
• Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease.

  1996cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance

  year unknowncited by this paper

• Targeting Inflammatory Imbalance in Chronic Kidney Disease: Focus on Anti-Inflammatory and Resolution Mediators

  2025cites this paper
• Intercellular adhesion molecule‐1 (ICAM‐1) associates with 24‐hour ambulatory blood pressure variability in type 2 diabetes and controls

  2019cites this paper
• The complex effects of adipokines in the patients with kidney disease

  2018cites this paper
• Adiponectin is related to markers of endothelial dysfunction and neoangiogenesis in diabetic patients

  2018cites this paper
• The Promise of Systems Biology for Diabetic Kidney Disease.

  2018cites this paper
• Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria.

  2017cites this paper
• Adiponectin and chronic kidney disease; a review on recent findings

  2015influential citation
• Association of adiponectin polymorphisms with the risk of diabetic nephropathy in type 2 diabetes: A meta‐analysis 脂联素基因多态性与2型糖尿病肾病的相关性：一项meta分析

  2015cites this paper
• Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathway

  2014cites this paper
• Adiponectin gene polymorphisms in Egyptian type 2 diabetes mellitus patients with and without diabetic nephropathy

  2014cites this paper
• Low serum endothelial cell-selective adhesion molecule predicts increase in albuminuria in type 2 diabetes patients

  2013cites this paper
• Adipokines promote chronic kidney disease.

  2013cites this paper
• The predictive value of serum intercellular adhesion molecule 1 for the progression of diabetic kidney disease in type 2 diabetic patients

  2013cites this paper
• VIKOR method for diabetic nephropathy risk factors analysis.

  2013cites this paper
• Adiponectin: An Adipokine with Multiple Faces

  2013cites this paper
• Hierarchy of risk factors for chronic kidney disease in patients with type 2 diabetes mellitus

  2012cites this paper
• Association of 276G>T adiponectin gene polymorphism to plasma adiponectin and albuminuria in type 2 diabetic patients

  2012cites this paper
• L’adiponectine : une adipokine aux multiples visages

  2012cites this paper
• The complex role of adiponectin in chronic kidney disease.

  2012cites this paper